Gm Advisory Group, Inc. Immunity Bio, Inc. Transaction History

Gm Advisory Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$5.05 - $7.53 $96,237 - $143,499	-19,057 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$5.67 - $10.18 $41,334 - $74,212	7,290 Added 61.95%	19,057 $116,000
Q3 2021 Nov 12, 2021	BUY	$9.17 - $14.24 $4,172 - $6,479	455 Added 4.02%	11,767 $115,000
Q2 2021 Aug 16, 2021	BUY	$13.41 - $22.4 $21,858 - $36,512	1,630 Added 16.84%	11,312 $162,000
Q1 2021 May 13, 2021	BUY	$12.83 - $42.25 $124,220 - $409,064	9,682 New	9,682 $230,000

202

70M

1.68M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.8B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Gm Advisory Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Gm Advisory Group, Inc. with notifications on news.